Lipopolysaccharide (LPS) treatment decreases the density of neurons in the ischemic cortical region after stroke in a microglia-dependent manner. by Eric Yuhsiang Wang (17131666)

KA/E2 induced allergic airway inflammation via TLR2. by Mi-Kyung Park (56053)

Subjects:

Cathepsin B and uPAR knockdown decreases Cdk2 activity and the expression of αVβ3 integrin. by Sreelatha Gopinath (238422)

Nrf2 activation decreases PMN ROS production in response to zymosan. by Doumet Georges Helou (7255823)

V2 vasopressin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…Immortalized HBECs with (A) lenti-<i>KRas</i>^V12, (B) lenti-<i>KRas</i>^V12 and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i>^V12, sh<i>p53</i>, and <i>myc</i> overexpression. …”

HAI-2 deficiency leads to decreased proliferation of intestinal epithelium. by Roman Szabo (138655)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…The height of each bar indicates the fold change, from vehicle- to isoginkgetin-treated cells, in the mean fraction of reads aligning to each genic feature (<i>p</i><0.02 from two-tailed <i>t</i>-tests for all ratios). (<b>B</b>) Isoginkgetin treatment increases the “guillotine” base height (<i>p</i> = 10⁻¹²) of intronic expression without increasing the blade height (<i>p</i> = 0.5), consistent with a splicing defect (compare to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1A</a>). …”

AICAR-activated AMPK decreased SREBP-2 protein levels. by Shudong Liu (733425)

Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

“…</i> time showing that AVP did not affect the basal EC LIII-CA2 EPSP recorded before HFS stimulation. E) Left, Typical graph of the fEPSP evoked by Schaffer collaterals stimulation and recorded in a CA1 pyramidal neuron (SC-CA1); AVP did not affect the amplitude of the LTP-potentiated EPSP , as shown on the average graph (Right, n = 4).…”

RNF5 depletion decreases cellular gene expression and lytic replication through increased EphA3 and EphA4 level in iSLK.219 cells. by Xiaojuan Li (351842)

Bortezomib decreases osteoclasts and improves fracture repair in mice. by Hengwei Zhang (2397610)

MyD88^-/- mice have decreased levels of cytokines in the conjunctiva. by Rose Y. Reins (2586106)

Ibuprofen and diclofenac decrease migration. by Verena Leidgens (815986)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…<b>(D)</b> HR [hazard ratio] of 1.72, p<1x10^-16). <b>(E)</b> Similar analysis of 2,061 patients with ER⁺ breast cancer (HR 1.48, p = 5.5x10^-6). …”

Effect of NAC on decreased MYH expression caused by arecoline in C2C12 cells. by Yi-Xuan Li (6633845)

Ibuprofen and diclofenac decrease proliferation. by Verena Leidgens (815986)

“…<p>Proliferation was analyzed using crystal violet staining and results were verified via the CyQuant Direct Cell Proliferation assay in HTZ-349. (A) Starting at 72 h, all ibuprofen concentrations (0.5, 1, 2 mM) resulted in significant reduction of HTZ-349 proliferation (compared to non-treated Ctrl, 95% CI, p < 0.05). 2 mM ibuprofen caused significant proliferation inhibition at 24 h (0.01 > p ≤ 0.001) and 48 h (p < 0.0001). …”

LGP2 overexpression decreases the transcript levels of the IFN signaling and proinflammatory cytokines during ZIKV infection. by Zhongyuan Tan (5779016)

TSLPR deficient mice show decreased AHR upon HDM exposure. by Latifa Koussih (326043)